Susquehanna International Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Susquehanna International Group’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-26,183	Closed	-$175K	–	13596
2023 Q3	$175K	Sell	26,183 -7,038	-21%	-$58.5K	﹤0.01%	10377
2023 Q2	$301K	Sell	33,221 -78,955	-70%	-$696K	﹤0.01%	9426
2023 Q1	$816K	Buy	112,176 +86,784	+342%	+$644K	﹤0.01%	7357
2022 Q4	$185K	Sell	25,392 -38,739	-60%	-$287K	﹤0.01%	10245
2022 Q3	$496K	Sell	64,131 -32,614	-34%	-$277K	﹤0.01%	8519
2022 Q2	$659K	Sell	96,745 -337,256	-78%	-$2.58M	﹤0.01%	7593
2022 Q1	$3.46M	Buy	+434,001	New	+$2.76M	﹤0.01%	4350

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Susquehanna International Group's PNT Position: Q4 2023 in Review

Susquehanna International Group sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 26,183 shares — an estimated $175K sold.

Susquehanna International Group first reported a position in PNT in Q1 2022 and held it in 7 quarters. The position peaked at $3.46M in Q1 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Susquehanna International Group reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Susquehanna International Group sold 26,183 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $175K.
Susquehanna International Group first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Susquehanna International Group's POINT Biopharma Global Inc. Common Stock position peaked at $3.46M in Q1 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.